Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoo-P: Zoledronate for Pneumonia Prevention in Hip Fracture
NCT05743179Phase 4Recruiting
- Sponsor
- The University of Hong Kong
- Start
- Dec 2022
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of zoledronate in pneumonia (2 arms), sponsored by The University of Hong Kong. Primary endpoint: Pneumonia hospitalizations at 12 months. Started Dec 2022; status: recruiting.
02
Drugs
zoledronate
03
Conditions
pneumonia
Beyond the preview
Go deeper on NCT05743179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05743179.